ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,983.99
      -0.29%
      US Tech 100
      20,522.40
      -0.15%
      Dow Jones
      43,910.98
      -0.86%
      Brent Oil
      71.645
      -0.25%
      Bitcoin
      88,704.64
      -0.05%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Brazil
      5. BOV

      6. Novo Nordisk (N1VO34) Quote

      Novo Nordisk

      Novo Nordisk (N1VO34)

      BOV
      77.17
      -1.58
      (-2.01%)
      Closed November 12 3:55PM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      76.65
      Bid
      76.65
      Ask
      77.70
      Volume
      5,790
      76.44 Day's Range 77.36
      58.60 52 Week Range 103.10
      Market Cap
      2.633T
      Previous Close
      78.75
      Open
      77.00
      Last Trade
      19
      @
      76.65
      Last Trade Time
      Financial Volume
      R$ 443,873
      VWAP
      76.662
      Average Volume (3m)
      8,588
      Shares Outstanding
      34,350,000,000
      Dividend Yield
      -
      PE Ratio
      44.33
      Earnings Per Share (EPS)
      2.44
      Revenue
      232.26B
      Net Profit
      83.68B

      About Novo Nordisk

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.novonordisk.com
      Headquarters
      Bagsvaerd, Dnk
      Founded
      -
      Novo Nordisk is listed in the Pharmaceutical Preparations sector of the Brazil Bovespa Exchange with ticker N1VO34. The last closing price for Novo Nordisk was R$78.75. Over the last year, Novo Nordisk shares have traded in a share price range of R$ 58.60 to R$ 103.10.

      Novo Nordisk currently has 34,350,000,000 shares outstanding. The market capitalization of Novo Nordisk is R$2.71 trillion. Novo Nordisk has a price to earnings ratio (PE ratio) of 44.33.

      Ask ADVFN Intelligence (AI)

      N1VO34 Latest News

      More News
      No news to show yet.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-2.32-2.9378244903178.9780.2274.8499177.83404625DR
      4-7.79-9.2254855518784.448574.8569081.39713315DR
      12-14.98-16.348357524891.6310074.8858888.59184205DR
      26-7.15-8.5322195704183.8103.174.8891190.98558057DR
      5214.6523.629032258162103.158.6718585.32064313DR
      15638.37100.23510971838.28103.130.36450867.23809258DR
      26051.475204.46871896725.175103.121.75399962.39621323DR

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      TTEN33TENTOS ON NM
      R$ 14.18
      (16.32%)
      		7.37M
      LJQQ3Lojas Quero-Quero SA
      R$ 3.05
      (9.71%)
      		12.67M
      BMEB4Bco Mercantil Brasil Sa
      R$ 39.99
      (8.67%)
      		24.6k
      GEPA3Rio Paranapanema Energia S.A.
      R$ 33.50
      (7.72%)
      		100
      RENT3Localiza Rent A Car
      R$ 45.46
      (6.79%)
      		32.06M
      OIBR3Oi
      R$ 1.00
      (-60.00%)
      		31.22M
      MBLY11Mobly S.A.
      R$ 0.10
      (-52.38%)
      		15.3k
      RCSL4Recrusul Sa
      R$ 1.50
      (-21.05%)
      		9.4M
      OIBR4Oi
      R$ 9.79
      (-12.59%)
      		160.8k
      CEDO3Cia Fiacao Tecidos Cedro Cachoeira
      R$ 22.00
      (-12.00%)
      		200
      HAPV3Hapvida Participacoes Investimento SA
      R$ 3.31
      (4.42%)
      		79.44M
      PETR4Petroleo Brasileiro S.A. Petrobras
      R$ 36.93
      (1.88%)
      		39.41M
      RENT3Localiza Rent A Car
      R$ 45.46
      (6.79%)
      		32.06M
      COGN3CognaEducacao SA
      R$ 1.40
      (-5.41%)
      		32.01M
      OIBR3Oi
      R$ 1.00
      (-60.00%)
      		31.22M

      Discussion

      View Full Feed
      Richard H2 Richard H2 2 minutes ago
      Ah, the interminable saga of Ron Loudoun and Astra—a quintessential exemplar of calculated obfuscation and sheer ineptitude. Loudoun’s perpetual carousel of evasive disclosures and spurious assertions constitutes nothing less than a masterclass in deceptive theatrics, adeptly ensnaring investors wit
      ASRE
      Hugie Hugie 2 minutes ago
      It will be falling until the expected news.
      ZHUD
      cptbac cptbac 2 minutes ago
      Probably don’t want to show manipulation on their part regardless of the PR worthiness. That’s my take and not look to go back and forth with anyone.
      NWBO
      cptbac cptbac 2 minutes ago
      Probably don’t want to show manipulation on their part regardless of the PR worthiness. That’s my take and not look to go back and forth with anyone.
      NWBO
      Willy Willy 2 minutes ago
      https://www.linkedin.com/in/rafael-gorgal-5055623/
      beartrap12 beartrap12 2 minutes ago
      Collaborations with companies, completed negations with one:

      Collaborations: Complementary or Synergistic Technologies. The Company has also been pursuing ongoing efforts to identify and develop collaborations with other companies who have technologies that the Company believes may be
      NWBO
      Bud-Wiser Bud-Wiser 2 minutes ago
      One tick up a day is Fantastic 
      CGAC
      StockItOut StockItOut 2 minutes ago
      Then you're hopeless.
      XERI
      Red_Right_Hand Red_Right_Hand 2 minutes ago
      yep
      NWBO
      glenn1919 glenn1919 3 minutes ago
      muln..............a/h
      FeMike FeMike 3 minutes ago
      The Company currently anticipates that the DCVax-Direct program will be able to restart by the end of January.
      NWBO
      dinogreeves dinogreeves 3 minutes ago
      No, you are.
      AFFU
      BillyRaven BillyRaven 3 minutes ago
      That answers my question, thank you
      BLEG
      beartrap12 beartrap12 4 minutes ago
      10Q Collaberations with clinics
      Collaborations: Private Clinics. As previously reported, the Company has been working over the last couple of years and during this year to develop certain clinical collaborations. These include joint efforts by the Company and Advent BioServices to establish c
      NWBO
      Iggy_Bot Iggy_Bot 4 minutes ago
      Thank you for sharing, ...
      WNFT
      FeMike FeMike 4 minutes ago
      Collaborations: Complementary or Synergistic Technologies. The Company has also been pursuing ongoing efforts to identify and develop collaborations with other companies who have technologies that the Company believes may be complementary to the Company’s DCVax technologies (for example for combinat
      NWBO
      IB_ IB_ 5 minutes ago
      Bernard "Buddy" Berk !!!!!!!!!!!!!!!!!!

      IB_🤴
      ELTP
      boston745 boston745 5 minutes ago
      Companies Website indicates they have not exited the armor market. The next quote indicates the only thing they "exited" was their Armor facility in Salt Lake. The third quote indicates that R&D costs will continued development of "ceramic armor products". In fact in quote 4, they are pursuing the d
      SINT
      beartrap12 beartrap12 5 minutes ago
      new. Reembursement review and evaluation process
      10Q:
      Reimbursement. The Company has evaluated and selected specialized, highly experienced consultants with whom to undertake preparations for a potential reimbursement review and evaluation process. The Company has executed the relevant
      NWBO
      CometNebula81 CometNebula81 5 minutes ago
      Good new I
      say
      FNMA
      quester614 quester614 5 minutes ago
      Just CAN"T FIX a STUPID ANTAGONISTIC FLIPTARD who needs BEER MONEY.
      XERI
      Lakota-45 Lakota-45 6 minutes ago
      A Notice to the Board; The I-ON Digital Corp Security Details was updated,
      again today, - at OTC Markets - Tuesday, November 12, 2024 !!!
      Note; ( No change on the OS, but - Plans for a - "RS"
      was announced on September 20, 2024 !!! )

      ~ Note - The Company Info. h
      IONI
      Lite Lite 6 minutes ago
      Hope he gets called to the Principal’s Office and gets explained why and what they are going to accomplish. Maybe that will change his smug look.
      FNMA
      Sleepy$$$ Sleepy$$$ 6 minutes ago
      See you at .005 $HIRU
      HIRU

      Your Recent History

      BOV
      N1VO34
      Novo Nordisk
      USOTC
      CAPS
      Capstone Therapeutics (QB)
      BIT
      P21HQ0
      NLBNPIT21HQ0 20241218 42...
      TSXV
      PRG
      Precipitate Gold
      NASDAQ
      WHLR
      Wheeler Real Estate Inve...
      Delayed Upgrade Clock